Literature DB >> 26294359

Tolosa-Hunt syndrome: an arcane pathology of cavernous venous sinus.

Adeel Arshad1, Shahzaib Nabi2, Muhammad Siyab Panhwar3, Ali Rahil1.   

Abstract

Tolosa-Hunt syndrome, an idiopathic granulomatous inflammation of the cavernous sinus, is primarily a diagnosis of exclusion. The majority of patients present with unilateral orbital pain and features suggestive of paralysis of one or more of the cranial nerves passing through the cavernous sinus and/or superior orbital fissure. MRI of the head may show unilateral enhancement of the cavernous sinus and orbital apex. Treatment is with high-dose intravenous steroids followed by tapering oral steroids. Rapid amelioration of pain within 24-48 h supports this rare diagnosis. Resolution of neuropathies may take longer. We describe a case of a young man who presented with left periorbital pain, complete ophthalmoplaegia and ptosis of the left eye. MRI showed enhancement of the left cavernous sinus and orbital apex. High dose steroids led to complete resolution of pain, while ptosis and ophthalmoplaegia improved gradually. 2015 BMJ Publishing Group Ltd.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26294359      PMCID: PMC4550974          DOI: 10.1136/bcr-2015-210646

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  13 in total

1.  [Tolosa-Hunt syndrome: a case report].

Authors:  Marijan Kovacić; Ivan Kovacić; Ana Krvavica; Ivica Nekić; Mladen Harapin
Journal:  Lijec Vjesn       Date:  2010 May-Jun

Review 2.  An approach to the patient with painful ophthalmoplegia, with a focus on Tolosa-Hunt syndrome.

Authors:  Jonathan P Gladstone
Journal:  Curr Pain Headache Rep       Date:  2007-08

3.  Idiopathic Tolosa-Hunt syndrome: four additional cases.

Authors:  D Kirbas; B Topcular; M E Ozcan; Sakalli N Karagoz; G Gul; Aslan I Kalyoncu
Journal:  Ideggyogy Sz       Date:  2008-07-30       Impact factor: 0.427

4.  A comparison of benign and inflammatory manifestations of Tolosa-Hunt syndrome.

Authors:  Chih-Hsien Hung; Kuo-Hsuan Chang; Yi-Ming Wu; Yao-Liang Chen; Rong-Kuo Lyu; Hong-Shiu Chang; Yih-Ru Wu; Chiung-Mei Chen; Chin-Chang Huang; Chun-Che Chu; Ming-Feng Liao; Yau-Yau Wai; Shih-Pin Hsu; Long-Sun Ro
Journal:  Cephalalgia       Date:  2013-03-08       Impact factor: 6.292

5.  [Tolosa-Hunt syndrome].

Authors:  Anna Péterfi; Péter Zádori; Gábor Süto; Gyula Horváth; János Kopa
Journal:  Ideggyogy Sz       Date:  2011-01-30       Impact factor: 0.427

6.  Painful ophthalmoplegia: a case of Tolosa-Hunt syndrome.

Authors:  Mohenish K Singh; Brittany Marshall; John Hawley
Journal:  Mil Med       Date:  2014-11       Impact factor: 1.437

7.  Probable Tolosa-Hunt syndrome with a normal MRI.

Authors:  Mahmoud Abdelghany; Daniel Orozco; William Fink; Christopher Begley
Journal:  Cephalalgia       Date:  2014-06-17       Impact factor: 6.292

8.  Tolosa-Hunt syndrome--diagnostic problem of painful ophthalmoplegia.

Authors:  Jelena Paović; Predrag Paović; Ivica Bojković; Mirjana Nagulić; Vojislav Sredović
Journal:  Vojnosanit Pregl       Date:  2012-07       Impact factor: 0.168

9.  Tolosa-Hunt syndrome misdiagnosed as sinusitis complication.

Authors:  V A Lachanas; G T Karatzias; I Tsitiridis; I Panaras; V G Sandris
Journal:  J Laryngol Otol       Date:  2008-01       Impact factor: 1.469

10.  Factors that influence Tolosa-Hunt syndrome and the short-term response to steroid pulse treatment.

Authors:  Xingwen Zhang; Wei Zhang; Ruozhuo Liu; Zhao Dong; Shengyuan Yu
Journal:  J Neurol Sci       Date:  2014-03-21       Impact factor: 3.181

View more
  2 in total

1.  A 17-Year-Old Girl With Unilateral Headache and Double Vision.

Authors:  Larissa G Rodriguez-Homs; Mark Goerlitz-Jessen; Samrat U Das
Journal:  J Investig Med High Impact Case Rep       Date:  2019 Jan-Dec

2.  The demographics of Tolosa-Hunt syndrome in Qatar.

Authors:  Fateen Ata; Zohaib Yousaf; Suresh Nalaka Menik Arachchige; Saman Rose; Awni Alshurafa; Bassam Muthanna; Ammara Bint I Bilal; Ahmed El Beltagi; Muhammad Zahid
Journal:  eNeurologicalSci       Date:  2021-07-22
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.